Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123238) titled 'An exploratory clinical study of YMN-C01 injection in the treatment of relapsed/refractory acute myeloid leukemia' on April 23.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: West China Hospital, Sichuan University
Condition:
Acute myeloid leukemia (AML)
Intervention:
Low dose experimental group:YMN-C01 injection, 2 mg/dose, intravenous infusion on D0, D2, and D4
Recruitment Status: Not Recruiting
Phase: 1
Date of First Enrollment: 2026-05-01
Target Sample Size: Low dose experimental group:6;High dose experimental group:6;
Countries of Recruitment:
China
To know more, vi...